Literature DB >> 24368116

Surgical outcomes after intraocular lens implantation for posterior lenticonus-related cataract according to preoperative lens status.

Byung Joo Lee1, Jeong Hun Kim1, Young Suk Yu2.   

Abstract

PURPOSE: To address the surgical outcomes of pediatric patients with cataracts associated with posterior lenticonus who required cataract extraction and intraocular lens (IOL) implantation according to preoperative lens status.
SETTING: Department of Ophthalmology, Seoul National University Children's Hospital, Seoul, South Korea.
DESIGN: Comparative case series.
METHODS: Patients who had cataract extraction and IOL implantation for posterior lenticonus were divided into 2 groups according to the preoperative lens status. Clinical features and visual outcomes in both groups were comparatively analyzed.
RESULTS: Forty-seven eyes of 43 patients were studied. Thirty-five eyes had lens opacities localized to the posterior pole, and 12 eyes presented with total opacity of the lens. Preexisting posterior capsule defect was identified intraoperatively in 11 eyes with total lens opacity. Eyes with preexisting posterior capsule defects more frequently required ciliary sulcus fixation of the IOL (P=.01). The mean follow-up after cataract extraction was 66.9 months ± 35.9 (SD). The mean final corrected distance visual acuity of patients with total opacity (0.37 ± 0.57 logMAR) was better than that of patients with posterior polar opacity (0.56 ± 0.50 logMAR), with borderline significance (P=.05).
CONCLUSIONS: A preexisting posterior capsule defect, found most often in eyes that presented with total lens opacity, could be an obstacle to capsular bag fixation of the IOL. Posterior lenticonus patients with total lens opacity had marginally significantly better visual outcomes than patients with posterior polar opacity. FINANCIAL DISCLOSURE: No author has a financial or proprietary interest in any material or method mentioned.
Copyright © 2013 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24368116     DOI: 10.1016/j.jcrs.2013.07.048

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  7 in total

1.  Newer insights into the clinical profile of posterior lenticonus in children and its surgical, visual, refractive outcomes.

Authors:  Ramesh Kekunnaya; Ajinkya V Deshmukh; Sampada Kulkarni
Journal:  Eye (Lond)       Date:  2021-05-06       Impact factor: 4.456

2.  Posterior optic capture of intraocular lens in difficult cases of pediatric cataract.

Authors:  Jaspreet Sukhija; Savleen Kaur; Shagun Korla
Journal:  Indian J Ophthalmol       Date:  2022-01       Impact factor: 1.848

3.  Posterior lenticonus with persistent fetal vasculature.

Authors:  Sudarshan Khokhar; Chirakshi Dhull; Karthikeyan Mahalingam; Pulak Agarwal
Journal:  Indian J Ophthalmol       Date:  2018-09       Impact factor: 1.848

4.  Clinical profile and surgical outcomes in children with posterior lenticonus.

Authors:  Divya Harshwardhan Jain; Sumita Agarkar; Hennaav Kaur Dhillon
Journal:  Oman J Ophthalmol       Date:  2021-02-27

5.  Intraoperative OCT for the assessment of posterior capsular integrity in pediatric cataract surgery.

Authors:  Wan Chen; Zhuangling Lin; Qiaolin Zhu; Duoru Lin; Hui Chen; Jinghui Wang; Jingjing Chen; Qiwei Wang; Xianghua Wu; Zhuoling Lin; Xiaoshan Lin; Xiaoyan Li; Jing Li; Haotian Lin; Weirong Chen
Journal:  J Cataract Refract Surg       Date:  2022-03-01       Impact factor: 3.528

6.  Comment on: Progressive posterior lenticonus with total lenticular opacity.

Authors:  Nirupama Kasturi; Vignesh Elamurugan
Journal:  Indian J Ophthalmol       Date:  2019-10       Impact factor: 1.848

7.  Clinical Characteristics and Surgical Safety in Congenital Cataract Eyes with Three Pathological Types of Posterior Capsule Abnormalities.

Authors:  Xixia Ding; Linfeng Xiang; Qianwei Wang; Dandan Wang; Pingjun Chang; Zhangliang Li; Yinying Zhao; Feixue Chu; Chao Ma; Yun-E Zhao
Journal:  J Ophthalmol       Date:  2020-03-16       Impact factor: 1.909

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.